Moreover, the relationship between PD-L1 and IRF2BP2 in cancer cells was also investigated by Soliman et al. (2014), who associated low IRF2BP2 levels with high PD-L1 expression in breast cancer cells (Soliman et al., 2014). The gene discussed is IRF2BP2; the disease is breast carcinoma.